IGF-I, IGFBP-3 and breast cancer in young women : a pooled re-analysis of three prospective studies
作者： Sabina Rinaldi , Paolo Toniolo , Paola Muti , Eva Lundin , Anne Zeleniuch-Jacquotte
DOI: 10.1097/00008469-200512000-00001
关键词:
摘要: Prospective cohort studies on breast cancer risk among premenopausal women and insulin-like growth factor I (IGF-I) concentrations have so far included only few cases, shown inconsistent relative estimates. We pooled 220 cases of diagnosed before age 50, 434 control subjects, from three prospective in New York (USA), Umea (Northern Sweden) Milan (Italy), we measured IGF-I binding protein 3 (IGFBP-3) with common enzyme-linked immunosorbent assays. Overall, IGFBP-3 measurements obtained by the method showed a positive but not significant relationship (odds ratios (ORs) 0.90 [95% confidence intervals (95% CI) 0.50-1.62], 1.63 [0.89-2.97], 1.46 [0.78-2.73] 1.41 [0.75-2.63] for quintiles IGF-I, ORs 0.98 [0.54-1.75], 1.06 [0.59-1.91], 1.04 [0.58-1.87] 1.77 [0.97-3.24] IGFBP-3). Our results give moderate support an association blood young women.
elsevier.com
sci-hub.se 参考文章(14)
Rudolf Kaaks, Eva Lundin, Jonas Manjer, Sabina Rinaldi, Carine Biessy, Stefan Söderberg, Per Lenner, Lars Janzon, Elio Riboli, Göran Berglund, Göran Hallmans, Prospective study of IGF-I, IGF-binding proteins, and breast cancer risk, in Northern and Southern Sweden Cancer Causes & Control. ,vol. 13, pp. 307- 316 ,(2002) , 10.1023/A:1015270324325
M. Elisabeth Del Giudice, I. George Fantus, Shereen Ezzat, Gail McKeown-Eyssen, David Page, Pamela J. Goodwin, Insulin and related factors in premenopausal breast cancer risk. Breast Cancer Research and Treatment. ,vol. 47, pp. 111- 120 ,(1998) , 10.1023/A:1005831013718
Rudolf Kaaks, Ingeborg van der Tweel, Paul A. H. van Noord, Elio Riboli, Efficient use of biological banks for biochemical epidemiology: exploratory hypothesis testing by means of a sequential t-test. Epidemiology. ,vol. 5, pp. 429- 438 ,(1994) , 10.1097/00001648-199407000-00009
J. M. Chan, Plasma Insulin-Like Growth Factor-I and Prostate Cancer Risk: A Prospective Study Science. ,vol. 279, pp. 563- 566 ,(1998) , 10.1126/SCIENCE.279.5350.563
John S. Witte, Sander Greenland, Lee-Lian Kim, Insulin-like growth factor-I in relation to premenopausal ductal carcinoma in situ of the breast. Epidemiology. ,vol. 9, pp. 570- 573 ,(1998) , 10.1097/00001648-199809000-00016
Peter F. Bruning, Jaap Van Doorn, Johannes M. G. Bonfrèr, Paul A. M. Van Noord, Catharina M. Korse, Theodora C. Linders, Augustinus A. M. Hart, Insulin‐like growth‐factor‐binding protein 3 is decreased in early‐stage operable pre‐menopausal breast cancer International Journal of Cancer. ,vol. 62, pp. 266- 270 ,(1995) , 10.1002/IJC.2910620306
J.P. Peyrat, M.M. Louchez, J. Lefebvre, J. Bonneterre, P. Vennin, A. Demaille, B. Helquet, C. Fournier, Plasma insulin-like growth factor-1 (IGF-1) concentrations in human breast cancer European Journal of Cancer. ,vol. 29, pp. 492- 497 ,(1993) , 10.1016/S0959-8049(05)80137-6
Susan E Hankinson, Walter C Willett, Graham A Colditz, David J Hunter, Dominique S Michaud, Bonnie Deroo, Bernard Rosner, Frank E Speizer, Michael Pollak, Circulating concentrations of insulin-like growth factor I and risk of breast cancer The Lancet. ,vol. 351, pp. 1393- 1396 ,(1998) , 10.1016/S0140-6736(97)10384-1
Franco Berrino, Holger J. Schünemann, Jo L. Freudenheim, Sabina Sieri, Teresa Quattrin, Brydon J. B. Grant, Brydon J. B. Grant, Maurizio Trevisan, Vittorio Krogh, Andrea Micheli, Paola Muti, Malathi Ram, Fasting glucose is a risk factor for breast cancer: a prospective study. Cancer Epidemiology, Biomarkers & Prevention. ,vol. 11, pp. 1361- 1368 ,(2002)
Rozlyn A Krajcik, Norman Orentreich, Nancy D Borofsky, Stephen Massardo, Insulin-like growth factor I (IGF-I), IGF-binding proteins, and breast cancer. Cancer Epidemiology, Biomarkers & Prevention. ,vol. 11, pp. 1566- 1573 ,(2002)